Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Evgen Pharma ( (GB:TCF) ) just unveiled an update.
TheraCryf Plc, a UK-based company, has announced a significant change in its voting rights structure. Tracarta Limited, based in the British Virgin Islands, has acquired 19.85% of TheraCryf’s voting rights, marking a notable shift from a previous position of 0%. This acquisition could impact TheraCryf’s strategic decisions and influence its market positioning.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 3,792,212
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £4.79M
Find detailed analytics on TCF stock on TipRanks’ Stock Analysis page.